In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...

In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs. HOUSTON — In a real-world setting, mepolizumab therapy significantly ...

Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...

Please provide your email address to receive an email when new articles are posted on . Moderate exacerbations shared similar characteristics with severe exacerbations. Lung function, limitations and ...

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep ...

In severe asthma, more exacerbations occur November through January, with respiratory infection as the most commonly identified trigger.

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Credit: Getty Images. Researchers assessed how the use of metformin affected asthma exacerbations in adolescents and young adults 12 to 21 years of age. Among patients aged 12 to 21 years with asthma, ...

Patients with asthma have high rates of type 2 inflammatory disease, study finds. A new study of nearly a quarter-million patients with asthma found a high percentage have at least one co-existing ...

Underlying mood and sleep disorders may negatively affect asthma control, researchers find. “Asthma control, sleep quality, and mood are all critical factors in affecting an individual’s overall ...

The following article is a part of conference coverage from the American Academy of Allergy, Asthma & Immunology Annual Meeting, being held in Phoenix, Arizona, from February 25 to 28, 2022. Click ...